Lexeo Therapeutics, Inc. (LXEO)
2.80
-0.10
(-3.61%)
USD |
NASDAQ |
Nov 06, 10:01
Lexeo Therapeutics Price : 2.80 for Nov. 6, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 05, 2026 | 3.23 | 3.37 | 2.775 | 2.905 | 1.707M |
| Nov 04, 2026 | 3.22 | 3.44 | 3.035 | 3.23 | 1.191M |
| Nov 03, 2026 | 3.10 | 3.30 | 3.010 | 3.11 | 1.309M |
| Nov 02, 2026 | 3.16 | 3.18 | 2.99 | 3.06 | 1.220M |
| Oct 30, 2026 | 3.02 | 3.295 | 2.90 | 3.14 | 1.002M |
| Oct 29, 2026 | 3.16 | 3.375 | 3.05 | 3.06 | 1.046M |
| Oct 28, 2026 | 2.85 | 3.14 | 2.78 | 3.13 | 1.198M |
| Oct 27, 2026 | 2.71 | 2.935 | 2.65 | 2.87 | 2.684M |
| Oct 26, 2026 | 2.80 | 2.825 | 2.675 | 2.70 | 1.163M |
| Oct 23, 2026 | 2.87 | 2.965 | 2.73 | 2.80 | 619383.0 |
| Oct 22, 2026 | 2.98 | 3.12 | 2.89 | 2.89 | 492468.0 |
| Oct 21, 2026 | 3.03 | 3.09 | 2.97 | 3.00 | 1.080M |
| Oct 20, 2026 | 2.76 | 3.055 | 2.71 | 3.02 | 1.276M |
| Oct 19, 2026 | 2.65 | 2.81 | 2.55 | 2.76 | 1.863M |
| Oct 16, 2026 | 2.75 | 2.84 | 2.63 | 2.64 | 2.507M |
| Oct 15, 2026 | 2.66 | 2.83 | 2.61 | 2.76 | 1.304M |
| Oct 14, 2026 | 2.70 | 2.785 | 2.56 | 2.63 | 1.943M |
| Oct 13, 2026 | 3.09 | 3.09 | 2.74 | 2.74 | 1.587M |
| Oct 12, 2026 | 3.22 | 3.22 | 3.04 | 3.04 | 1.048M |
| Oct 09, 2026 | 3.21 | 3.34 | 3.115 | 3.23 | 961383.0 |
| Oct 08, 2026 | 3.27 | 3.28 | 3.111 | 3.21 | 2.546M |
| Oct 07, 2026 | 3.27 | 3.465 | 3.22 | 3.31 | 1.195M |
| Oct 06, 2026 | 3.43 | 3.43 | 3.17 | 3.30 | 1.539M |
| Oct 05, 2026 | 3.56 | 3.655 | 3.37 | 3.41 | 1.859M |
| Oct 02, 2026 | 3.66 | 3.688 | 3.495 | 3.53 | 2.592M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Arrowhead Pharmaceuticals, Inc. | 57.79 |
| Oncolytics Biotech, Inc. | 0.4545 |
| Sangamo Therapeutics, Inc. | 0.114 |
| Sarepta Therapeutics, Inc. | 17.87 |
| Anixa Biosciences, Inc. | 3.02 |
Price Related Metrics
| Price to Book Value | 0.9366 |
| Earnings Yield | -41.34% |
| Market Cap | 220.14M |